quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:30:00·9d
PRRelease
Quantum-Si Incorporated logo

Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies

QSI· Quantum-Si Incorporated
Industrials
Original source

Companies

  • QSI
    Quantum-Si Incorporated
    Industrials

Recent analyst ratings

  • Feb 7UpdateAlliance Global Partners$3.75
  • Dec 8UpdateH.C. Wainwright$3.00
  • Sep 25UpdateCanaccord Genuity$2.00
  • Oct 20UpdateCanaccord Genuity$13.00

Related

  • INSIDER1d
    SEC Form 4 filed by Keyes Jeffry R.
  • INSIDER1d
    SEC Form 4 filed by Hawkins Jeffrey Alan
  • SEC1d
    SEC Form 144 filed by Quantum-Si Incorporated
  • SEC1d
    SEC Form 144 filed by Quantum-Si Incorporated
  • PR7d
    Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
  • PR8d
    Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting
  • PR13d
    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • PR15d
    Quantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype System
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022